{Reference Type}: Journal Article
{Title}: Tisotumab vedotin (Tivdak) for cervical cancer.
{Journal}: Med Lett Drugs Ther
{Volume}: 66
{Issue}: 1705
{Year}: 2024 Jun 24
{Factor}: 1.677
{DOI}: 10.58347/tml.2024.1705g